Actively Recruiting
Ultrathin Strut Sirolimus-eluting Stent With Bioabsorbable Polymer in Patients Receiving Chronic Oral Anticoagulation
Led by Fundación EPIC · Updated on 2026-04-22
500
Participants Needed
10
Research Sites
203 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Patients receiving chronic oral anticoagulation with indication for percutaneous coronary revascularization with stent implantation, and needing for antiplatelet therapy, are at high risk of bleeding. The new generation of ultrathin strut sirolimus-eluting stent with bioabsorbable polymer allow for shorter antiplatelets regimens and could be a good option for this high-bleeding risk patients.
CONDITIONS
Official Title
Ultrathin Strut Sirolimus-eluting Stent With Bioabsorbable Polymer in Patients Receiving Chronic Oral Anticoagulation
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Signed informed consent
- Age 18 years or older
- Receiving chronic oral anticoagulation treatment with any anticoagulant for any reason
- Diagnosed with de novo coronary artery disease requiring elective or urgent percutaneous revascularization for stable coronary artery disease or acute coronary syndrome with or without ST-segment elevation
- Use of an ultrathin strut sirolimus-eluting stent with bioabsorbable polymer during the procedure
You will not qualify if you...
- Treatment with any stent other than the SupraFlex Cruz stent in the 6 months before the study procedure
- Use of other stents different from the evaluated one during the same or scheduled procedures for other vessels
- Treatment for restenosis or stent thrombosis
- Presentation with cardiogenic shock or after cardiorespiratory arrest
- Allergy to any component of the stent
- Inability to complete follow-up
- Life expectancy less than 1 year
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 10 locations
1
Hospital General Universitario de Albacete
Albacete, Spain, 02008
Actively Recruiting
2
Hospital Universitario San Juan de Alicante
Alicante, Spain, 03550
Actively Recruiting
3
Hospital General Universitario de Merida
Badajoz, Spain, 6800
Actively Recruiting
4
Hospital General Universitari de Castelló
Castelló, Spain, 12004
Actively Recruiting
5
H.G.U. de Ciudad Real.
Ciudad Real, Spain, 13005
Actively Recruiting
6
Hospital General Universitari d'Elx
Elche, Spain, 03203
Actively Recruiting
7
Hospital Universitario de Canarias
Laguna, Spain, 38320
Actively Recruiting
8
Hospital Universitario Puerta de Hierro
Majadahonda, Spain, 28222
Actively Recruiting
9
Hospital Universitario de Navarra
Pamplona, Spain, 31008
Actively Recruiting
10
Hospital Clinico Universitario Lozano Blesa
Zaragoza, Spain, 50009
Actively Recruiting
Research Team
J
Juan Gabriel Córdoba Soriano, MD, PhD
CONTACT
F
FUNDACION EPIC
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here